Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4',5,7-trihydroxyflavanone
2. Be 14348a
3. Be-14348a
4. Naringenin-7-sulfate
1. 480-41-1
2. Salipurpol
3. Salipurol
4. (s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
5. (s)-naringenin
6. Pelargidanon
7. (2s)-naringenin
8. Naringetol
9. Naringenine
10. Asahina
11. Nsc 11855
12. Ccris 5839
13. (-)-naringenin
14. Yso1
15. Nsc 34875
16. (-)-(2s)-naringenin
17. Chembl9352
18. (s)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
19. Ai3-23355
20. Hn5425sbf2
21. Chebi:17846
22. Flavanone, 4',5,7-trihydroxy-
23. 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
24. 4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2s)-
25. Narigenin
26. Nsc-11855
27. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4h-chromen-4-one
28. 5,7,4'-trihydroxyflavanone
29. (r,s)-naringenin
30. Sr-01000721771
31. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
32. Unii-hn5425sbf2
33. 2uxu
34. 4deu
35. S-dihydrogenistein
36. Einecs 207-550-2
37. Pelargidanon 1602
38. Spectrum_000247
39. 4eh3
40. Naringenin [mi]
41. Spectrum2_000325
42. Spectrum3_000567
43. Spectrum4_000124
44. Spectrum5_001423
45. Naringenin [inci]
46. 4',5,7-trioh-flavone
47. 4',5,7-trihydroxyflavanon
48. Naringenin, (-)-
49. Schembl20570
50. Bspbio_001954
51. Kbiogr_000508
52. Kbioss_000727
53. Mls000574861
54. Bidd:er0116
55. Divk1c_000118
56. Spectrum1500746
57. Spbio_000329
58. 4',5, 7-trihydroxyflavanone
59. 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4h-chromen-4-one
60. Dtxsid1022392
61. Bdbm23419
62. Hms500f20
63. Kbio1_000118
64. Kbio2_000727
65. Kbio2_003295
66. Kbio2_005863
67. Kbio3_001454
68. 4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (s)-
69. Ninds_000118
70. (2s)-5,7,4'-trihydroxyflavone
71. Aids001417
72. Hms2202m06
73. Zinc156701
74. (2s)-4',5,7-trihydroxyflavanone
75. Hy-n0100
76. Tnp00287
77. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
78. (s)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone
79. Ccg-38601
80. Lmpk12140001
81. Phytochemistry 8: 127 (1969)
82. S2394
83. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-one
84. Akos016843490
85. Cs-6421
86. Db03467
87. Fs-4072
88. Sdccgmls-0066570.p001
89. (2s)-4',5,7-trihydroxyflavan-4-one
90. Idi1_000118
91. Ncgc00016457-01
92. Ncgc00016457-02
93. Ncgc00016457-03
94. Ncgc00017346-01
95. Ncgc00163598-01
96. Ac-33954
97. Cas-480-41-1
98. Flavanone, 4',5,7-trihydroxy- (8ci)
99. Smr000156272
100. Ft-0617134
101. Sw219329-1
102. C00509
103. A827427
104. Q418374
105. Q-100666
106. Sr-01000721771-3
107. Sr-01000721771-4
108. 5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-chroman-4-one
109. Brd-k08832567-001-02-4
110. Brd-k08832567-001-06-5
111. (-)-(2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
112. (s)-2,3-dihydo-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
113. 2,3-dihydro-5,6-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
114. 4h-1-benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2s)-
115. 13308-00-4
Molecular Weight | 272.25 g/mol |
---|---|
Molecular Formula | C15H12O5 |
XLogP3 | 2.4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 272.06847348 g/mol |
Monoisotopic Mass | 272.06847348 g/mol |
Topological Polar Surface Area | 87 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 363 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Estrogen Antagonists
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Naringenin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naringenin, including repackagers and relabelers. The FDA regulates Naringenin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naringenin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Naringenin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Naringenin supplier is an individual or a company that provides Naringenin active pharmaceutical ingredient (API) or Naringenin finished formulations upon request. The Naringenin suppliers may include Naringenin API manufacturers, exporters, distributors and traders.
click here to find a list of Naringenin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Naringenin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naringenin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Naringenin GMP manufacturer or Naringenin GMP API supplier for your needs.
A Naringenin CoA (Certificate of Analysis) is a formal document that attests to Naringenin's compliance with Naringenin specifications and serves as a tool for batch-level quality control.
Naringenin CoA mostly includes findings from lab analyses of a specific batch. For each Naringenin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naringenin may be tested according to a variety of international standards, such as European Pharmacopoeia (Naringenin EP), Naringenin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naringenin USP).
LOOKING FOR A SUPPLIER?